TNF-α enhances cardiac myocyte NO production through MAP kinase- mediated NF-κB activation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 4 46-4, 1999, Pages

  Kan, Hong ^a   Xie, Zirong ^a   Finkel, Mitchell S ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell signaling; Cytokines; Heart; Mitogen activated protein kinase; Nitric oxide; Tumor necrosis factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

EID: 0032692141     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.4.h1641     Document Type: Article

References (30)

1. Abbas, A. K., A. H. Lichtman, and J. S. Pober. Cytokines. In: Cellular and Molecular Immunology. Philadelphia, PA: Saunders, 1991, Chapt. 11, p. 226-242.
2. Balligand, J. L., D. Ungureanu-Longrois, W. W. Simmons, D. Pimental, T. A. Malinski, M. Kapturczak, Z. Taha, C. J. Lowenstein, A. J. Davidoff, R. A. Kelly, T. W. Smith, and T. Michel. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J. Biol. Chem. 269: 27580-27588, 1994.
3. Bredt, D. S., P. M. Hwang, C. E. Glatt, C. Lowenstein, R. R. Reed, and S. H. Snyder. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718, 1991.
4. Cohn, J. N., T. B. Levine, M. T. Olivari, V. Gaeberg, D. Lura, G. S. Francis, A. B. Simon, and T. Rector. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N. Engl. J. Med. 311: 819-823, 1984.
5. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. L. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992.
6. Haque, R., H. Kan, and M. S. Finkel. Effects of cytokines and nitric oxide on myocardial E-C coupling. Basic Res. Cardiol. 93, Suppl. 1: 86-94, 1998.
7. Ignarro, L. J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41: 485-490, 1991.
8. Janssens, S. P., A. Shimouchi, T. Quertermous, D. B. Bloch, and K. D. Bloch. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267: 14519-14522, 1992.
9. Kacimi, R., C. S. Long, and J. S. Karliner. Chronic hypoxia modulates the interleukin-1β-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation 96: 1937-1943, 1997.
10. Kan, H., Z. Xie, and M. S. Finkel. Norepinephrine stimulated MAP kinase activity enhances cytokine induced nitric oxide production by neonatal rat cardiac myocytes. Am. J. Physiol. 276 (Heart Circ. Physiol. 45): H47-H52, 1999.
11. Kaulik, N., M. Sato, B. D. Price, and D. K. Das. An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 429: 365-369, 1998.
12. Kumar, A., R. Brar, P. Wang, L. Dee, G. Skorupa, F. Khadour, R. Schulz, and J. E. Parrillo. Role of nitric oxide and cAMP in human septic serum-induced depression of cardiac myocyte contractility. Am. J. Physiol. 276 (Regulatory Integrative Comp. Physiol. 45): R265-R276, 1999.
13. Kumar, A., A. Middleton, T. C. Chambers, and K. D. Mehta. Differential role of extracellular signal-regulated kinase-1/2 and p38(MAPK) in interleukin-1β- and tumor necrosis factor-α-induced low density lipoprotein receptor expression in HepG2 cells. J. Biol. Chem. 273: 15742-15748, 1998.
14. Kuno, K., K. Sukegawa, Y. Ishikawa, T. Orii, and K. Matsushima. Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NF-κb activation. Int. Immunol. 6: 1269-1272, 1994.
15. Levine, B., J. Kalman, L. Mayer, H. M. Fillit, and M. Packer. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323: 236-241, 1990.
16. Meldrum, D. R. Tumor necrosis factor in the heart. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R577-R595, 1998.
17. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
18. Oddis, C. V., and M. S. Finkel. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem. Biophys. Res. Commun. 213: 1002-1009, 1995.
19. Oddis, C. V., and M. S. Finkel. NF-κB and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H1864-H1868, 1996.
20. Oddis, C. V., R. L. Simmons, B. G. Hattler, and M. S. Finkel. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H2044-H2050, 1995.
21. Parillo, J. E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477, 1993.
22. Roberts, A. B., Y. Vodovotz, A. S. Roche, M. B. Sporn, and C. F. Nathan. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol. Endocrinol. 6: 1921-1930, 1995.
23. Taylor, B. S., M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. Morris, T. R. Billiar, and D. A. Geller. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273: 15148-15156, 1998.
24. Thorburn, J., J. A. Frost, and A. Thorburn. Mitogen-activated protein kinase mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell Biol. 126: 1565-1572, 1994.
25. VanArsdale, T. L., and C. F. Ware. TNF receptor signal transduction: Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60. J. Immunol. 153: 3043-3050, 1994.
26. Walters, S. B., K. H. Holt, S. E. Ross, L. J. Syu, K. L. Guan, A. R. Saltiel, G. A. Koretzky, and J. E. Pessin. Desensitization of ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270: 20883-20886, 1995.
27. Winston, B. W., C. A. Lange-Carter, A. M. Gardner, G. L. Johnson, and D. W. Riches. Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-independent fashion in mouse macrophages. Proc. Natl. Acad. Sci. USA 92: 1614-1618, 1995.
28. Yang, X., M. Szabolcs, E. Athan, O. P. Minanov, R. R. Sciacca, M. Bianchi, P. Ulrich, K. J. Tracey, R. E. Michler, and P. J. Cannon. CNI-1493 reduces apoptosis and necrosis and prolongs survival during rat cardiac allograft rejection. Circulation 94: I-55, 1996.
29. Ye, Z. S., and H. H. Samuels. Cell- and sequence-specific binding of nuclear protein to 5́-flanking DNA of the rat growth hormone gene. J. Biol. Chem. 262: 6313-6317, 1987.
30. Yokoyama, T., M. Nakano, J. L. Bednarczyk, B. W. McIntyre, M. Entman, and D. L. Mann. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95: 1247-1252, 1997.